Reporting of adverse effects:
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that appears in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicinal Products for Human Use:www.notificaRAM.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Keep this medication out of the sight and reach of children.
This medication does not require special storage conditions.
Do not use this medication after the expiration date that appears on the packaging and labeling. The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.
Tamsulosina SUN Composition
- The active ingredient is tamsulosin hydrochloride. Each prolonged-release hard capsule contains 0.4 mg of tamsulosin hydrochloride.
- The other components (excipients) are:
Capsule content: microcrystalline cellulose PH101, magnesium stearate, copolymer dispersion of methacrylic acid/ethyl acrylate (1:1), sodium hydroxide, triacetin, titanium dioxide (E171), talc.
Capsule body: gelatin, yellow-orange S (E110), ponceau 4R (E124), yellow quinoline (E104), brilliant blue (E133), titanium dioxide (E171).
Capsule coating: gelatin, yellow iron oxide (E172), brilliant blue (E133), azorubine (E122), titanium dioxide (E171).
Printing ink: shellac, black iron oxide (E172), potassium hydroxide.
Product appearance and packaging contents
Tamsulosina SUN 0.4 mg prolonged-release hard capsules are presented in the form of orange/brown clear number 2 capsules, with an "R" printed on the cap and "TSN400" in the body, in black. The capsules contain white or almost white granules.
Tamsulosina SUN is presented in packaging of 1, 2, 4, 7, 10, 14, 20, 28, 30, 50, 56, 60, 90, 98, 100, or 200 prolonged-release capsules.
Only some packaging sizes may be commercially available.
Marketing authorization holder and manufacturer
Marketing authorization holder: |
Sun Pharmaceutical Industries Europe B.V., |
Polarisavenue 87, |
2132JH Hoofddorp, Netherlands |
Manufacturer: TERAPIA, S.A. 124 Fabricii Street Cluj-Napoca – Romania or Sun Pharmaceutical Industries Europe B.V. Polarisavenue 87 2132JH Hoofddorp Netherlands Local representative Sun Pharma Laboratorios, S.L. Rambla de Catalunya 53-55 08007 Barcelona. Spain Tel.: +34 93 342 78 90 |
Last reviewed date of this leaflet: March 2022
For detailed and updated information on this medicine, please visit the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.